Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Joshua F Ransom, PhD, Aaron Galaznik, MDMBA, Emelly Rusli, Bruno Lempernesse, MS, Marc Berger, MD

Blood (2019) 134 (Supplement_1): 4895.

https://doi.org/10.1182/blood-2019-129086

Published: 2019

Journal Articles

Blinatumomab + Ponatinib for Relapsed Ph1-Positive Acute Lymphoblastic Leukemia: The French Experience

Marie-Anne Couturier, MD, Xavier Thomas, MD, Francoise Huguet, MD, Céline Berthon, MD PhD, Célestine Simand, MD, Yosr Hicheri, Mathilde Hunault, MD PhD, Patrice Chevallier, MD

Blood (2018) 132 (Supplement 1): 4014.

https://doi.org/10.1182/blood-2018-99-111546

Published: 2018

Journal Articles

Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

Laura Janke, DVM, PhD, Jieun Kim, PhD, David Jenkins, BS, Monique A Payton, BS, Mary V Relling, PharmD, Seth E Karol, MD

Blood (2018) 132 (Supplement 1): 4029.

https://doi.org/10.1182/blood-2018-99-112941

Published: 2018

Journal Articles

Treatment-Free Remission (TFR) Among Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Not Initially Eligible for Treatment Discontinuation Due to Unstable Deep Molecular Response (DMR): Enestfreedom and Enestop

Timothy P. Hughes, MD, Andreas Hochhaus, MD, Dong-Wook Kim, MD PhD, Francois-Xavier Mahon, MD PhD, Francis J. Giles, MD MB, FRCPath, Jerald P. Radich, MD, David M Ross, MBBS, PhD FRACP, FRCPA, Prashanth Gopalakrishna, MD, Weiping Deng, Rafik Fellague-Chebra, MD, Sandip Acharya, MSc, Giuseppe Saglio, MD PhD

Blood (2017) 130 (Supplement 1): 2878.

https://doi.org/10.1182/blood.V130.Suppl_1.2878.2878

Published: 2017

Journal Articles

High Incidence of True Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia Antibody Development in Critically Ill Medical Patients

Noppacharn Uaprasert, MB, BCH, Siriporn Jutiamornlerd, MD, Rattaporn Vichitratchaneekorn, Benjaporn Akkawat, BSc, Ponlapat Rojnuckarin, MD PhD, Sunisa Kongkiatkamon, MD

Blood (2017) 130 (Supplement 1): 4646.

https://doi.org/10.1182/blood.V130.Suppl_1.4646.4646

Published: 2017

Journal Articles

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Upneet Chawla, BS, MD, Maureen Sampson, MT, Natasha A Jain, MD, Prathima Anandi, MD, Sawa Ito, MD PhD, Eleftheria Koklanaris, RN, Pawel Muranski, MD, John Barrett, MD, Marcus Y Chen, MD, Alan Remaley, MD PhD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 828.

https://doi.org/10.1182/blood.V128.22.828.828

Published: 2016

Journal Articles

Characteristics of Venous Thrombi in Animal Models of Obesity, Diabetes and Hypertension

Fernanda Dutra Santiago-Bassora, PhD, Aline Barnabé, PhD, Kiara Cristina Senger Zapponi, MSc, Anna Virginia Calazans Romano, MSc, Any Elisa de Souza Smidt Gonçalves, PhD, Mario Jose Abdalla Saad, MD PhD, Jose Antonio Diaz, MD, Erich Vinicius De Paula, MD PhD, Joyce Maria Annichino-Bizzacchi, MD PhD

Blood (2016) 128 (22): 5006.

https://doi.org/10.1182/blood.V128.22.5006.5006

Published: 2016

Journal Articles

the Polymorphisms on Chromosome 9p21 Play a Role in the Risk for Cardiovascular Events in Chronic Myeloid Leukemia Patients?

Federica Sora, MD, Patrizia Chiusolo, Laurenti Luca, Pola Roberto, Sabrina Giammarco, Gatto Ilaria, Andrea Bacigalupo, MD, Simona Sica, Abruzzese Elisabetta, Celesti Francesca

Blood (2016) 128 (22): 5100.

https://doi.org/10.1182/blood.V128.22.5100.5100

Published: 2016

Journal Articles

The Common PAR4 Ala120Thr Variant Has a Major Effect on Platelet Reactivity to Thrombin and These Effects Are Enhanced with PAR1 and P2Y12 Inhibition

Michael J. Whitley, Joanne Vesci, Michael Holinstat, PhD, Leonard C. Edelstein, PhD, Paul F. Bray, MD

Blood (2016) 128 (22): 709.

https://doi.org/10.1182/blood.V128.22.709.709

Published: 2016

Journal Articles

Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial

Blood (2015) 126 (23): 4046.

https://doi.org/10.1182/blood.V126.23.4046.4046

Published: 2015

Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD

Blood (2015) 126 (23): 4031.

https://doi.org/10.1182/blood.V126.23.4031.4031

Published: 2015

Journal Articles

Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults

Blood (2015) 126 (23): 4362.

https://doi.org/10.1182/blood.V126.23.4362.4362

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Antonella Isgro, MD, Javid Gaziev, Pietro Sodani, MD, Marco Andreani, PhD, Manuela Testi, PhD, Katia Paciaroni, MD, Cristiano Gallucci, MD, Gioia De Angelis, MD, Marco Marziali, MD, Cecilia Alfieri, MD, Michela Ribersani, MD, Olufemi O Akinyanju, T. Thompson Wakama, Festus Olusola Olowoselu, Guido Lucarelli, MD

Blood (2015) 126 (23): 4598.

https://doi.org/10.1182/blood.V126.23.4598.4598

Published: 2015

Journal Articles

Comparison Between Saddle Versus Non-Saddle Pulmonary Embolism: Insights from Nationwide Inpatient Sample

Ranjan Pathak, MD, Smith Giri, MD, Madan Raj Aryal, MD, Paras Karmacharya, MD, Anthony A Donato, MDMHPE

Blood (2014) 124 (21): 3514.

https://doi.org/10.1182/blood.V124.21.3514.3514

Published: 2014

Journal Articles

Predictors of in-Hospital Mortality in Tumor Lysis Syndrome

Ranjan Pathak, MD, Smith Giri, MD, Madan Raj Aryal, MD, Paras Karmacharya, MD, Prakash Thapaliya, MD, Anthony A Donato, MDMHPE

Blood (2014) 124 (21): 4862.

https://doi.org/10.1182/blood.V124.21.4862.4862

Published: 2014

Journal Articles

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Aurélie Jaspers, MD, Frederic Baron, MD PhD, Johan Maertens, MD PhD, Bernard J. M. De Prijck, MD, Henri (Rik) Schots, MDPhD, Christophe Bonnet, MD PhD, Kaoutar Hafraoui, MD, Evelyne Willems, MD PhD, Sophie Servais, MD PhD, Georges Fillet, MD PhD, Yves Beguin, MD PhD

Blood (2014) 124 (21): 3948.

https://doi.org/10.1182/blood.V124.21.3948.3948

Published: 2014

Journal Articles

Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort

Franck E. Nicolini, MD, PhD, Marie-Claude Gagnieu, PharmD, PhD, Mael Heiblig, MD, Emilie Blond, Pharm.D, Laurence Legros, MD, PhD, Yann Guillermin, MD, Stephane Morisset, Stat., Fiorenza Barraco, MD, Madeleine Etienne, CRA, Oriane Le Borgne, CRA, Jeremy Ruby, CRA student, Mohamad Sobh, Pharm.M., Gaelle Richard-Colmant, MD, Celine Fettig, Tech., Mauricette Michallet, MD, PhD, Delphine Rea, MD, PhD

Blood (2013) 122 (21): 4020.

https://doi.org/10.1182/blood.V122.21.4020.4020

Published: 2013

Journal Articles

Statin Use Was Associated With a Non-Significant Reduction In The Observed Incidence Of Recurrent VTE In Einstein-DVT and Einstein-PE

Martin Gebel, PhD, Martin Prins, MD, Anthonie WA Lensing, MD

Blood (2013) 122 (21): 1135.

https://doi.org/10.1182/blood.V122.21.1135.1135

Published: 2013

Journal Articles

Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center Cohort

Hélène Labussière-Wallet, MD, Yann Guillermin, MD, Madeleine Etienne, CRA, Anne-Claire Barale, Caroline Serrier, MD, Isabelle Tigaud, MD, Sandrine Hayette, Oriane Le Borgne, CRA, Mohamad Sobh, Pharm.M., Stephane Morisset, Stat., Fiorenza Barraco, MD, Mauricette Michallet, MD, PhD, Franck E. Nicolini, MD, PhD

Blood (2012) 120 (21): 3756.

https://doi.org/10.1182/blood.V120.21.3756.3756

Published: 2012

Journal Articles

Increased Transpulmonary Gradient Predicts Functional Class, Mortality, and RV Dysfunction by MRI in Patients with Sickle Cell Associated Pulmonary Hypertension

Kim-Lien Nguyen, M.D., Shoaib Alam, M.D., Xin Tian, Ph.D., Steve W. Leung, M.D., Catherine Seamon, Caterina Minniti, M.D., James G. Taylor, M.D., Vandana Sachdev, M.D., Andrew E. Arai, M.D., Gregory J. Kato, M.D.

Blood (2012) 120 (21): 89.

https://doi.org/10.1182/blood.V120.21.89.89

Published: 2012

NARROW

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Blinatumomab + Ponatinib for Relapsed Ph1-Positive Acute Lymphoblastic Leukemia: The French Experience

Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy

Treatment-Free Remission (TFR) Among Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Not Initially Eligible for Treatment Discontinuation Due to Unstable Deep Molecular Response (DMR): Enestfreedom and Enestop

High Incidence of True Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia Antibody Development in Critically Ill Medical Patients

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Characteristics of Venous Thrombi in Animal Models of Obesity, Diabetes and Hypertension

the Polymorphisms on Chromosome 9p21 Play a Role in the Risk for Cardiovascular Events in Chronic Myeloid Leukemia Patients?

The Common PAR4 Ala120Thr Variant Has a Major Effect on Platelet Reactivity to Thrombin and These Effects Are Enhanced with PAR1 and P2Y12 Inhibition

Prospective Metabolic and Cardiovascular Assessment in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib 300 Mg Bid Frontline in the Gimema 0811 Trial

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults

Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

Comparison Between Saddle Versus Non-Saddle Pulmonary Embolism: Insights from Nationwide Inpatient Sample

Predictors of in-Hospital Mortality in Tumor Lysis Syndrome

Long-Term Safety Follow-up of a Randomized Trial of Darbepoetin Alpha and Intravenous Iron Following Autologous Hematopoietic Cell Transplantation

Cardio-Vascular Events Occurring On Ponatinib In Chronic Phase Chronic Myeloid Leukemia Patients, Preliminary Analysis Of a Multicenter Cohort

Statin Use Was Associated With a Non-Significant Reduction In The Observed Incidence Of Recurrent VTE In Einstein-DVT and Einstein-PE

Analysis of Clinical Arterial and Metabolic Parameters in Chronic Phase CML Patients On Nilotinib in a Single Center Cohort

Increased Transpulmonary Gradient Predicts Functional Class, Mortality, and RV Dysfunction by MRI in Patients with Sickle Cell Associated Pulmonary Hypertension

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only